N/A N=25 Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Cholangiocarcinoma
Primary: Median Progression Free Survival (PFS) — 6 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=167 Comparison of Two Marketed Silicone Hydrogel Lenses
Refractive Error
Primary: Mean Ex-vivo Cholesterol Deposits After 30 Days of Wear — 1.63; 4.89 micrograms
N/A N=60 Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Abortion, Induced
Primary: Patient Discomfort With Digoxin Injection (Pain Score) — 2.21; 1.88 Units on a scale — p=0.36
Phase 4 N=34 Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children
Influenza
Primary: Number of Subjects Shedding Vaccine Virus of Each Subtype by PCR — 1; 6; 9; 1 participants
N/A N=386 Efficacy of Segmental Examination Twice of the Proximal Colon on Adenoma Detection
Colonic Polyps
Primary: Difference of Adenoma Detection Rate in the Proximal Colon Among 2 Group. — 0.236; 0.331 proportion of participants
N/A N=25 In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.
Anesthesia
Primary: r Time — 5.6; 4.2; 3.9; 6 minutes
N/A N=1,718 Prevalence and Treatment of Anal Incontinence (AI) in Primiparous Women
Fecal Incontinence
Primary: Change in Anal Incontinence as Measured on the St. Mark's Score — 4.3; 4.5; 3.6; 4.1 units on a scale
N/A N=109 Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions
Port-A-Cath Placement · Octylcyanoacrylate
Primary: Number of Participants With Complication of Wound Dehiscence — 0; 0 participants
Phase 2 N=28 Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia
Spatial Neglect · Dysphagia
Primary: P50 Percent Habituation Score — -44.12; -45.84; 113.63; 61.41 percentage of change in amplitude
Phase 2 N=44 Non-cutting Laser Therapy in the Treatment of Acne
Acne Vulgaris
Primary: Change From Baseline in Papule Acne Lesions at Week 10 — -4.63; -0.13 papule acne lesions — p=0.01
Phase 3 N=59 ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism
Submassive Pulmonary Embolism
Primary: Reduction of RV/LV Ratio — 0.03; 0.30 Ratio
Phase 1 N=40 A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours
Solid Tumour
Primary: Number of Patients Experiencing Dose Limiting Toxicity (DLT) — 0; 0; 0; 1 Number of patients with DLT
Phase 2 N=173 Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
Chronic Iron Overload Due to Transfusion-dependant Anemias
Primary: Overall Safety as Measured by Frequency of Adverse Events — 89.5; 89.7; 15.1; 18.4 Percentage of participants
Phase 1 N=97 A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers
Healthy Volunteer
Primary: Area Under the Plasma Concentration-Time Curve From Time Zero to Extrapolated Infinite Time (AUC[0-inf]) of Alectinib — 1920; 1840; 1850; 1630 ng*hour/mL
Phase 3 N=91 Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature
Idiopathic Short Stature (ISS)
Primary: Number of Participants With One or More Drug-related Adverse Events — 42; 38; 11; 9 participants